Print Article for : Process Chemistry In The Pharmaceutical Industry

Your Online Guide » Human Resource Career » Human Resource Recruitment

[P701]Process Chemistry In The Pharmaceutical Industry

by Stephen Trigg, Ste

The UK pharmaceutical industry is one of the most dynamic and crucial sectors of the economy. Each year, the revenue this sector generates accounts for much of the national GDP figures. Furthermore, the majority of the drugs consumed within the UK are produced by UK pharmaceutical companies. This is not surprising as there are more pharmaceutical companies in the UK than anywhere else in Europe. This also means that the UK is the largest manufacturer of pharmaceuticals in the continent. Like the bio-tech industry, the pharmaceutical industry is also currently facing the challenge of increasing production costs. The introduction of new recruitment regulations have the potential to further increase these costs. Aside from the cost problems, the industry is also facing stagnating investment. This is mainly due to the fact that investors in this sector have very low business confidence.

Just like the bio-tech sector, the pharmaceutical industry is one in which Quanta has experience and specialized knowledge. Hence, Quanta is able to provide competent advice and guidance on pharmaceutical recruitment.As always, when it comes to recruiting subjects, pharmaceutical companies must ensure that they meet all government recruitment regulations. They must also make certain that all guidelines on health and safety are fully met. Failure to comply with all recruitment rules and regulations will usually result in fines and legal action. The new government regulation on age discrimination could result in pharmaceutical companies altering the way they recruit staff. In response to this recruitment legislation, more employers may begin to place more stringent job requirements on their vacancies. This will inevitable lead to higher levels of unemployment among lower qualified applicants.

In order to avoid breach, the new regulation also requires that Pharmaceutical companies must train and educate their staff on all aspects of the recruitment legislation. The extra investment involved in this could further increase the costs within the industry. Therefore, more employers within the sector may begin to outsource jobs overseas. They would do this in order to obtain benefits of cheaper labor and scale economies. The effect of this could mean higher redundancies and rates of unemployment within the pharmaceutical industry. Having said this, the new regulation will certainly give opportunities to applicants who might otherwise have been overlooked. It remains to be seen to what extent recruitment regulations will affect both investment and rising costs in the pharmaceutical industry.

Emerging third world markets to big drug companies has come to be the same as California gold was to miners in the 1800's. Every major drug company is clamoring to get their stake in these emerging markets, and is stopping at nothing to do it. But just as many of the biggest drug making companies in the world have their sights clearly set on these emerging markets, many of these countries are turning to generic drugs instead. This has always been the trend in less developed areas of the world, but analysts expect as the middle classes in most of these developing nations grow, there will be more of a demand for branded medicines, that may be more expensive, but are seen as having better quality.

That is why it is no surprise that the acquisition of generic drug companies, by larger branded drug corporations, is on the rise. As these larger drug companies are scrambling to buy the rights to generic drugs they can sell from their own, better trusted brand, companies like Wal-Mart and Kroger are clamoring to get a piece of the action. These companies know if they can buy generic drugs from these emerging markets at bottomed out prices, they can sell them in their retail outlets for a large profit. Cheap copycat generic drugs are becoming a necessity to some of these retail pharmaceutical companies because their losing more and more money everyday to well established drug companies, while at the same time having these cheap drugs attracts more customers to their stores.

But according to many in the pharmaceutical sales consulting industry, this may be a dangerous trend. Because companies like Wal-Mart and Kroger are most likely buying their generic drugs from poorer countries like India and Indonesia, this is causing a big concern about the quality of the drugs. The FDA is trying to crack down on the rising sales of generics from emerging markets to the U.S and other European countries, but the truth is, there's really not much they can do about it. As the need for cheaper, more available drugs continues to rise, there will be no choice but to turn to generic drugs on a massive scale.

But the large drug companies have not thrown in the towel just yet. With the emergence of generic drugs in these emerging markets, drug companies have started to turn more to generic branded medicine of their own. They have decided to buy the rights of much of this generic medicine themselves, so they can put their brand on it, giving it more legitimacy in markets around the world. With all that being said, there's one thing we do know, that this is only the beginning of a colossal struggle between the smaller generic drug companies and the large branded drug corporations.

If you enjoyed this article, please feel free to post it to your site or blog and forward this link to your friends. Have a great day!

Don't forget to visit our blog.

Article Source : Pg. 3

About Author

Both Stephen Trigg & Nigel Smart are contributors for EditorialToday. The above articles have been edited for relevancy and timeliness. All write-ups, reviews, tips and guides published by EditorialToday.com and its partners or affiliates are for informational purposes only. They should not be used for any legal or any other type of advice. We do not endorse any author, contributor, writer or article posted by our team.

Stephen Trigg has sinced written about articles on various topics from Careers and Job Hunting, Other Business and Careers and Job Hunting. Stephen Trigg is the CEO of Quanta Consultancy Services, the leader provider of .. Stephen Trigg's top article generates over 135000 views. to your Favourites.

Nigel Smart has sinced written about articles on various topics from High Cholesterol, SEO Search Engine Optimization and Team Building. Nigel Smart is a with extensive experience in the biotechnology and pharmaceutical industry. With Denise Smart, he manages Smart Consulti. Nigel Smart's top article generates over 22200 views. to your Favourites.